Brain Metastasis in Breast Cancer Patients—Need for Improvement

Brain Metastasis in Breast Cancer Patients—Need for Improvement

The incidence of brain metastases (BM) in breast cancer patients is increasing [...]

Bibliographic Details
Main Authors:	Isabell Witzel, Leticia Oliveira-Ferrer, Volkmar Müller
Format:	Article
Language:	English
Published:	MDPI AG 2020-10-01
Series:	Cancers
Subjects:	breast cancer brain metastases treatment diagnosis HER2 hormone receptor
Online Access:	https://www.mdpi.com/2072-6694/12/11/3190

Similar Items

A solitary brain metastasis as the only site of recurrence of HR positive, HER2 negative breast cancer: a case report and review of the literature
by: Sandipkumar H Patel, et al.
Published: (2021-01-01)

An Insight into Molecular Targets of Breast Cancer Brain Metastasis
by: Mohammed Kaleem, et al.
Published: (2022-10-01)

Impact of AKT1 on cell invasion and radiosensitivity in a triple negative breast cancer cell line developing brain metastasis
by: Joanna Kempska, et al.
Published: (2023-07-01)

Treatment options for patients with human epidermal growth factor 2-positive breast cancer brain metastases: A systematic review and meta-analysis
by: Xingfa Huo, et al.
Published: (2023-02-01)

Clonality of circulating tumor cells in breast cancer brain metastasis patients
by: Carlotta Riebensahm, et al.
Published: (2019-09-01)

Recurrent and Metastatic Characteristics and Prognosis of Advanced HER2-positive Breast Cancer Patients with Different HR Status
by: REN Yulin, et al.
Published: (2019-01-01)

Multidisciplinary precision treatment of brain metastasis in breast cancer: a case report
by: Chang Haiyan, Cheng Jing
Published: (2023-02-01)

Conversion of ER, PR, HER2 and Ki-67 and Prognosis in breast cancer metastases to the brain
by: Chen Jiaxin, et al.
Published: (2022-10-01)

Characteristics and Clinical Outcome of Breast Cancer Patients with Asymptomatic Brain Metastases
by: Elena Laakmann, et al.
Published: (2020-09-01)

Key Role of Hyaluronan Metabolism for the Development of Brain Metastases in Triple-Negative Breast Cancer
by: Fabienne Hamester, et al.
Published: (2022-10-01)

A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases
by: Eurydice Angeli, et al.
Published: (2024-04-01)

Intracranial Efficacy of Pyrotinib and Capecitabine Combination Therapy in HER2-Positive Breast Cancer with Brain Metastases
by: Wang C, et al.
Published: (2024-03-01)

Dramatic Recovery of Vision after Trastuzumab Deruxtecan Treatment of HER2-Positive Breast Cancer with Pituitary Metastasis
by: Chiaki Matsui, et al.
Published: (2023-07-01)

Interaction between HER-2 and Hormone Receptors in Breast Cancer
by: Majid Moghadaszadeh, et al.
Published: (2010-10-01)

Interaction between HER-2 and Hormone Receptors in Breast Cancer
by: Majid Moghadaszadeh, et al.
Published: (2010-12-01)

Landscape of Epidermal Growth Factor Receptor Heterodimers in Brain Metastases
by: Malcolm Lim, et al.
Published: (2022-01-01)

Effects of Whole-brain Radiotherapy Combined with Targeted Therapy on Improving Survival of HER2-positive Breast Cancer Patients with Brain Metastases
by: LI Zhensheng, et al.
Published: (2018-11-01)

Linac-Based Radiosurgery for Patients With Brain Oligometastases From a Breast Primary, in the Trastuzumab Era-Impact of Tumor Phenotype and Prescribed SRS Dose
by: Kevin Armstrong, et al.
Published: (2019-05-01)

All-oral combination of lapatinib and capecitabine in patients with brain metastases from HER2-positive breast cancer – A phase II study
by: Hanan Shawky, et al.
Published: (2014-12-01)

Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores
by: Kerstin Riecke, et al.
Published: (2021-02-01)

Local hero: A phase II study of local therapy only (stereotactic radiosurgery and / or surgery) for treatment of up to five brain metastases from HER2+ breast cancer. (TROG study 16.02)
by: Claire Phillips, et al.
Published: (2024-04-01)

Systemic Therapy for Patients with HER2-Positive Breast Cancer and Brain Metastases: A Systematic Review and Meta-Analysis
by: Inge M. Werter, et al.
Published: (2022-11-01)

Brain Metastases of Her2-Positive Breast Cancer: A Case of 34 Months' Remission with Lapatinib plus Capecitabine
by: Audrey Mailliez, et al.
Published: (2014-08-01)

Management of Brain and Leptomeningeal Metastases from Breast Cancer
by: Alessia Pellerino, et al.
Published: (2020-11-01)

Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift
by: Edy Ippolito, et al.
Published: (2022-03-01)

First diagnosed invasive lobular carcinoma of the breast combined with gastric metastasis and bone metastasis: a case report and review of the literature
by: Lin Sun, et al.
Published: (2023-03-01)

Molecular Mechanisms Associated with Brain Metastases in HER2-Positive and Triple Negative Breast Cancers
by: Sarah Bryan, et al.
Published: (2021-08-01)

Breast Cancer in Kirkuk City, Hormone Receptors Status (Estrogen and Progesterone) and Her-2/Neu and Their Correlation with Other Pathologic Prognostic Variables
by: Mahmoud Mohammed Mahmoud
Published: (2019-11-01)

Breast Cancer in Kirkuk City, Hormone Receptors Status (Estrogen and Progesterone) and Her-2/Neu and Their Correlation with Other Pathologic Prognostic Variables
by: Mahmoud Mohammed Mahmoud
Published: (2019-11-01)

Trastuzumab emtansine of the treatment of HER2-positive breast cancer with brain metatases
by: L. Yu. Vladimirova, et al.
Published: (2020-12-01)

Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases
by: María J. Contreras-Zárate, et al.
Published: (2017-11-01)

Brain metastases in her2-positive breast cancer: new opportunities for systemic therapy
by: E V Artamonova, et al.
Published: (2015-06-01)

Smoking history and breast cancer risk by pathological subtype: MCC-Spain study
by: Belén Peñalver-Argüeso, et al.
Published: (2023-11-01)

Correlation of histological grade with Estrogen, Progesterone and HER2/neu reactivity in breast cancer
by: Girishma Shrestha, et al.
Published: (2019-09-01)

Iraqi Breast Cancer: A Review on Patients' Demographic Characteristics and Clinico-Pathological Presentation.
by: Nada A. S. Alwan
Published: (2010-04-01)

New insights into HER2-low breast cancer brain metastasis: A retrospective analysis
by: Hangcheng Xu, et al.
Published: (2024-02-01)

Real-world patient characteristics, treatment patterns, and clinical outcomes associated with tucatinib therapy in HER2-positive metastatic breast cancer
by: Peter A. Kaufman, et al.
Published: (2023-10-01)

HER2-positive breast cancer with brain metastasis: long-lasting response after lapatinib treatment
by: Alessia D'Alonzo, et al.
Published: (2018-06-01)

Real-world data of HER2-low metastatic breast cancer: A population based cohort study
by: Emily I. Holthuis, et al.
Published: (2022-12-01)

ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis
by: Sara Charmsaz, et al.
Published: (2020-11-01)